๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Spontaneous remission of multilobated non-Hodgkin lymphoma

โœ Scribed by Andrew P. Grigg; George R. Gray; Dr. John D. Shepherd


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
446 KB
Volume
40
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

โœฆ Synopsis


A 67-year-old previously well man was admitted with hypercalcemia after a 7-day history of fever, night sweats, and back pain. The blood showed 5% multilobated lymphoid cells. A multilobated non-Hodgkin lymphoma associated with marked reticulin fibrosis was diagnosed on a bone marrow biopsy. During the next 7 days, in the absence of specific therapy, his symptoms disappeared. Three weeks after admission his biochemical abnormalities had resolved and after 9 weeks his bone marrow examination was normal. He remains in clinical and laboratory remission 16 months after presentation.


๐Ÿ“œ SIMILAR VOLUMES


Spontaneous regression in non-Hodgkin's
โœ H. H. Gattiker; E. Wiltshaw; D. A. G. Galton ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 428 KB ๐Ÿ‘ 2 views
Non-Hodgkin lymphoma of the prostate
โœ John Steuter; Dennis D. Weisenburger; R. Greg Bociek; Philip Bierman; Julie Vose ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 324 KB
Interferon therapy of non-Hodgkin's lymp
โœ Kenneth A. Foon; Mark S. Roth; Paul A. Bunn Jr ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 459 KB ๐Ÿ‘ 1 views

In 1981, the National Cancer Institute undertook Phase I1 trials of interferon alfa-2a in patients with non-Hodgkin's lymphoma (including cutaneous T-cell lymphoma [CTCL]) and chronic lymphocytic leukemia (CLL). A dose of 50 X lo6 U/m2, three times per week, was used initially, then adjusted downwar